Literature DB >> 18339004

Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model.

G Serviddio1, F Bellanti, R Tamborra, T Rollo, A D Romano, A M Giudetti, N Capitanio, A Petrella, G Vendemiale, E Altomare.   

Abstract

BACKGROUND: Mitochondrial dysfunction is considered a key player in non-alcoholic steatohepatitis (NASH) but no data are available on the mitochondrial function and ATP homeostasis in the liver during NASH progression. In the present paper we evaluated the hepatic mitochondrial respiratory chain activity and ATP synthesis in a rodent model of NASH development.
MATERIALS AND METHODS: Male Wistar rats fed a High Fat/Methionine-Choline Deficient (MCD) diet to induce NASH or a control diet (SHAM), and sacrificed after 3, 7 and 11 weeks. The oxidative phosphorylation, the F(0)F(1)ATPase (ATP synthase) and the ATP content were assessed in liver mitochondria.
RESULTS: NASH mitochondria exhibited an increased rate of substrate oxidation at 3 weeks, which returned to below the normal level at 7 and 11 weeks, concomitantly with the coupling between the phosphorylation activity and the mitochondrial respiration (ADP/O). Uncoupling of NASH liver mitochondria did not allow the recovery of the maximal respiration rate at 7 and 11 weeks. The ATPase (ATP synthase) activity was similar in NASH and SHAM rats, but the mitochondrial ATP content was significantly lower in NASH livers.
CONCLUSIONS: The loss of hepatic ATP stores is not dependent on the F(0)F(1)-ATPase but resides in the respiratory chain. Dysfunction of both Complex I and II of the mitochondrial respiratory chain during NASH development implies a mitochondrial adaptive mechanism occurring in the early stages of NASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339004     DOI: 10.1111/j.1365-2362.2008.01936.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  36 in total

Review 1.  Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Metin Basaranoglu; Serra Kayacetin; Nevin Yilmaz; Ertugrul Kayacetin; Orhan Tarcin; Abdullah Sonsuz
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats.

Authors:  Mélissa Flamment; Jennifer Rieusset; Hubert Vidal; Gilles Simard; Yves Malthièry; Bernard Fromenty; Pierre-Henri Ducluzeau
Journal:  J Physiol Biochem       Date:  2012-01-26       Impact factor: 4.158

3.  Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease.

Authors:  Panu K Luukkonen; Taru Tukiainen; Anne Juuti; Henna Sammalkorpi; P A Nidhina Haridas; Onni Niemelä; Johanna Arola; Marju Orho-Melander; Antti Hakkarainen; Petri T Kovanen; Om Dwivedi; Leif Groop; Leanne Hodson; Amalia Gastaldelli; Tuulia Hyötyläinen; Matej Orešič; Hannele Yki-Järvinen
Journal:  JCI Insight       Date:  2020-03-12

Review 4.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

Review 5.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

6.  Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.

Authors:  Ryan E Feaver; Banumathi K Cole; Mark J Lawson; Stephen A Hoang; Svetlana Marukian; Brett R Blackman; Robert A Figler; Arun J Sanyal; Brian R Wamhoff; Ajit Dash
Journal:  JCI Insight       Date:  2016-12-08

Review 7.  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

Authors:  Alexandra K Leamy; Robert A Egnatchik; Jamey D Young
Journal:  Prog Lipid Res       Date:  2012-11-23       Impact factor: 16.195

8.  Glutamate-oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux.

Authors:  Robert A Egnatchik; Alexandra K Leamy; Sarah A Sacco; Yi Ern Cheah; Masakazu Shiota; Jamey D Young
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

9.  Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet.

Authors:  Gaetano Serviddio; Anna M Giudetti; Francesco Bellanti; Paola Priore; Tiziana Rollo; Rosanna Tamborra; Luisa Siculella; Gianluigi Vendemiale; Emanuele Altomare; Gabriele V Gnoni
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

10.  Transition between acute and chronic hepatotoxicity in mice is associated with impaired energy metabolism and induction of mitochondrial heme oxygenase-1.

Authors:  Aniket Nikam; Jay V Patankar; Carolin Lackner; Elisabeth Schöck; Dagmar Kratky; Kurt Zatloukal; Peter M Abuja
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.